A Threshold Regression Mixture Model for Assessing Treatment Efficacy in a Multiple Myeloma Clinical Trial

ISSN： 1054-3406

Source： Journal of Biopharmaceutical Statistics, Vol.18, Iss.6, 2008-11, pp. : 1136-1149

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The mechanism of action, pharmacokinetics, and clinical efficacy of carfilzomib for the treatment of multiple myeloma

By Pautasso Chiara Bringhen Sara Cerrato Chiara Magarotto Valeria Palumbo Antonio

Expert Opinion on Drug Metabolism and Toxicology, Vol. 9, Iss. 10, 2013-10 ,pp. : 1371-1379

Informa Healthcare

Access to resources Recommend Favorite

Assessing the Efficacy of Drugs for the Acute Treatment of Migraine: Issues in Clinical Trial Design

By Ramadan N.M.

CNS Drugs, Vol. 16, Iss. 3, 2002-01 ,pp. : 181-196

Adis International

Access to resources Recommend Favorite

Panobinostat for the treatment of multiple myeloma

By Neri Paola Bahlis Nizar J Lonial Sagar

Expert Opinion on Investigational Drugs, Vol. 21, Iss. 5, 2012-05 ,pp. : 733-747

Informa Healthcare

Access to resources Recommend Favorite

Interferon-Alpha in the Treatment of Multiple Myeloma

Current Drug Targets, Vol. 12, Iss. 3, 2011-03 ,pp. : 437-446

Bentham Science Publishers

Access to resources Recommend Favorite

Recent Advances in the Treatment of Multiple Myeloma

Current Pharmaceutical Biotechnology, Vol. 7, Iss. 5, 2006-10 ,pp. : 381-393

Bentham Science Publishers

Access to resources Recommend Favorite